Literature DB >> 1284642

Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis.

L G Johnson1, J C Olsen, B Sarkadi, K L Moore, R Swanstrom, R C Boucher.   

Abstract

An important issue for in vivo gene therapy for cystic fibrosis (CF) is the percentage of cells within the CF airway that will require correction. In this study, we mixed populations of a CF airway cell line expressing either the normal cystic fibrosis transmembrane conductance regulator (CFTR) cDNA (corrected cells) or a reporter gene in defined percentages. As few as 6-10% corrected cells within an epithelial sheet generated C1-transport properties similar to sheets comprised of 100% corrected cells. Cell-cell coupling may serve as the mechanism for amplification of the functional effects of corrected cells. These data suggest that in vivo correction of all CF airway cells may not be mandatory.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1284642     DOI: 10.1038/ng0992-21

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  119 in total

Review 1.  Gene transfer for cystic fibrosis.

Authors:  M J Welsh
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 2.  Status of gene therapy for cystic fibrosis lung disease.

Authors:  R C Boucher
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 3.  Prospects for gene therapy in cystic fibrosis.

Authors:  A Jaffé; A Bush; D M Geddes; E W Alton
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

4.  In vivo retroviral gene transfer into human bronchial epithelia of xenografts.

Authors:  J F Engelhardt; J R Yankaskas; J M Wilson
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 5.  The potential for stem cell therapy in cystic fibrosis.

Authors:  Helen Spencer; Adam Jaffe
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

6.  Cell surface rescue of kidney anion exchanger 1 mutants by disruption of chaperone interactions.

Authors:  Sian T Patterson; Reinhart A F Reithmeier
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

7.  Optimization of hCFTR lung expression in mice using DNA nanoparticles.

Authors:  Linas Padegimas; Tomasz H Kowalczyk; Sam Adams; Chris R Gedeon; Sharon M Oette; Karla Dines; Susannah L Hyatt; Ozge Sesenoglu-Laird; Olena Tyr; Robert C Moen; Mark J Cooper
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

8.  Optimization of targeted cell replacement therapy: a new approach for lung disease.

Authors:  Pascal Duchesneau; Amy P Wong; Thomas K Waddell
Journal:  Mol Ther       Date:  2010-07-20       Impact factor: 11.454

9.  Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.

Authors:  Anna R Kwilas; Mark A Yednak; Liqun Zhang; Rachael Liesman; Peter L Collins; Raymond J Pickles; Mark E Peeples
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

10.  Retrovirus-mediated gene transfer to cystic fibrosis airway epithelial cells: effect of selectable marker sequences on long-term expression.

Authors:  J C Olsen; L G Johnson; M L Wong-Sun; K L Moore; R Swanstrom; R C Boucher
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.